|
|
|
Insider
Information: |
Gibertini Michael |
Relationship: |
President, Clinical Dev |
City: |
Raleigh |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
78,360 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,367,913 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
78,360 |
|
|
Total
Value |
$3,367,913 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Syneos Health Inc |
SYNH |
President, Clinical Dev |
2017-08-01 |
78,360 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2015-01-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
77,870 |
|
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2015-05-07 |
4 |
S |
$29.68 |
$1,484,000 |
D/D |
(50,000) |
27,870 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,412 |
36,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2015-11-02 |
4 |
OE |
$8.45 |
$76,050 |
D/D |
9,000 |
45,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2015-11-02 |
4 |
AS |
$41.70 |
$375,300 |
D/D |
(9,000) |
36,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2015-12-01 |
4 |
AS |
$45.71 |
$418,662 |
D/D |
(9,000) |
36,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2015-12-01 |
4 |
OE |
$8.45 |
$76,050 |
D/D |
9,000 |
45,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-01-04 |
4 |
OE |
$8.45 |
$76,050 |
D/D |
9,000 |
45,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-01-04 |
4 |
AS |
$46.47 |
$421,493 |
D/D |
(9,000) |
36,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
47,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-02-01 |
4 |
OE |
$8.45 |
$76,050 |
D/D |
9,000 |
56,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-02-01 |
4 |
AS |
$40.45 |
$365,152 |
D/D |
(9,000) |
47,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-03-01 |
4 |
AS |
$39.85 |
$358,677 |
D/D |
(9,000) |
47,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-03-01 |
4 |
OE |
$8.45 |
$76,050 |
D/D |
9,000 |
56,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-04-01 |
4 |
OE |
$8.45 |
$76,050 |
D/D |
9,000 |
56,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-04-01 |
4 |
AS |
$40.78 |
$367,038 |
D/D |
(9,000) |
47,282 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-06-06 |
4 |
OE |
$8.45 |
$1,738,615 |
D/D |
186,096 |
65,034 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-06-06 |
4 |
AS |
$43.05 |
$9,223,171 |
D/D |
(213,966) |
19,412 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-06-30 |
4 |
D |
$38.13 |
$33,669 |
D/D |
(883) |
18,529 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President Clinical Development |
|
2016-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
29,110 |
47,639 |
0 |
- |
|
SYNH |
Syneos Health Inc |
Chief Operating Officer |
|
2017-01-19 |
4 |
D |
$50.55 |
$42,310 |
D/D |
(837) |
46,802 |
0 |
- |
|
SYNH |
Syneos Health Inc |
Chief Operating Officer |
|
2017-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,567 |
57,369 |
0 |
- |
|
SYNH |
Syneos Health Inc |
Chief Operating Officer |
|
2017-06-30 |
4 |
D |
$58.50 |
$33,696 |
D/D |
(576) |
56,793 |
0 |
- |
|
SYNH |
Syneos Health Inc |
President, Clinical Dev |
|
2017-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,567 |
78,360 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|